Alkermes Pharmaceuticals is a leading pharmaceutical company known for its innovative medicines that fulfill the unmet needs and challenges of people living with debilitating diseases. It is a fully integrated global biopharmaceutical company that applies its scientific expertise, proprietary technologies and global resources to develop products. These products are designed to make a meaningful difference in the way people manage their disease.
The company has proven scientific, development and manufacturing capabilities through their records. Alkermes Pharmaceuticals is uniquely positioned to be the leader of innovative treatments for major clinical conditions mainly focused on central nervous system conditions like schizophrenia, depression, addiction, and multiple sclerosis.
The success of the leading company is reflected in its records that have proven its expertise in a diversified commercial product portfolio, known for a pipeline of novel product candidates focused on CNS diseases in clinical development, proprietary science, and technology.
The company has a commitment to developing new solutions for major diseases with people’s needs in mind. Combined with its resources and strong global presence, the position of Alkermes Pharmaceuticals as a leading innovator in the global pharmaceutical market, today and for the future.